WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock Ownership - Who owns Genmab A?

Insider buying vs selling

Have Genmab A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GMAB insiders and whales buy or sell their stock.

GMAB Shareholders

What type of owners hold Genmab A stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alliancebernstein LP23.63%15,614,510$445.95MInstitution
Blackrock Inc6.67%4,409,575$125.94MInstitution
Capital International Investors6.14%4,057,922$115.89MInstitution
Harding Loevner LP4.98%3,289,895$93.96MInstitution
Wellington Management Group LLP3.59%2,369,331$67.67MInstitution
Renaissance Technologies LLC2.26%1,494,800$42.69MInstitution
First Trust Advisors LP1.92%1,270,095$36.27MInstitution
Morgan Stanley1.65%1,089,097$31.10MInstitution
Envestnet Asset Management Inc1.40%925,918$26.44MInstitution
Bank Of America Corp1.35%889,164$25.39MInstitution

1 of 3

GMAB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GMAB70.53%0.00%
ALNY80.88%19.12%Net SellingNet Selling
BMRN98.08%1.63%Net SellingNet Selling
RPRX51.02%16.51%Net SellingNet Buying
BNTX17.05%0.00%

Genmab A Stock Ownership FAQ

Who owns Genmab A?

Genmab A (NASDAQ: GMAB) is owned by 70.53% institutional shareholders, 0.00% Genmab A insiders, and 29.47% retail investors. Alliancebernstein LP is the largest individual Genmab A shareholder, owning 15.61M shares representing 23.63% of the company. Alliancebernstein LP's Genmab A shares are currently valued at $444.55M.

If you're new to stock investing, here's how to buy Genmab A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.